World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
8488
World Ranking
4083
National Ranking
359

Overview

Antonella Folgori is affiliated with the University of Oxford in the United Kingdom. Their research spans multiple fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these areas, their subfields of study include Infectious Diseases, Immunology, Molecular Biology, Genetics, and Hepatology.

Their work addresses a range of scientific topics, notably:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research
  • Hepatitis C virus research
  • Viral gastroenteritis research and epidemiology
  • Immune Cell Function and Interaction

Antonella Folgori has contributed to several recent scientific papers, including:

  • "Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection," 2021, published in New England Journal of Medicine
  • "New viral vectors for infectious diseases and cancer," 2020, published in Seminars in Immunology
  • "A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability," 2020, published in Cancer Research
  • "MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans," 2020, published in Science Translational Medicine
  • "GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults," 2021, published in Science Translational Medicine

Their frequent co-authors include Stefania Capone, Stefano Colloca, Stefano Milleri, Roberto Camerini, and Alessandra M. Contino.

Regular publication venues for their work include bioRxiv (Cold Spring Harbor Laboratory), npj Vaccines, Science Translational Medicine, New England Journal of Medicine, and Seminars in Immunology.

Best Publications

  • Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

    Eleanor Barnes;Eleanor Barnes;Antonella Folgori;Stefania Capone;Leo Swadling

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

    Antonella Folgori;Stefania Capone;Lionello Ruggeri;Annalisa Meola

  • A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

    Leo Swadling;Stefania Capone;Richard D. Antrobus;Anthony Brown

  • A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.

    A. Folgori;R. Tafi;A. Meola;F. Felici

  • Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins

  • Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

    Stefano Colloca;Eleanor Barnes;Antonella Folgori;Virginia Ammendola

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Prime-boost vectored malaria vaccines: progress and prospects.

    Adrian V S Hill;Arturo Reyes-Sandoval;Geraldine O'Hara;Katie Ewer

  • Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries

    Franco Felici;Alessandra Luzzago;Antonella Folgori;Riccardo Cortese

  • Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer

    Silvia Zucchelli;Stefania Capone;Elena Fattori;Antonella Folgori

  • Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.

    Armelle Phalipon;Antonella Folgori;Josette Arondel;Giuseppe Sgaramella

  • IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

    Heiyoung Park;Elisavet Serti;Onyinyechi Eke;Brian Muchmore

  • Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

    Kimberly Page;Michael T Melia;Rebecca T Veenhuis;Matthew Winter

  • Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

    C A Green;E Scarselli;C J Sande;A J Thompson

  • Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization

    Kylie M. Quinn;Andreia Da Costa;Ayako Yamamoto;Dana Berry

  • CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.

    Fergusson;M H Hühn;L Swadling;L J Walker;L J Walker

  • A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques

    Stefania Capone;Annalisa Meola;Bruno Bruni Ercole;Alessandra Vitelli

  • MAIT cell activation augments adenovirus vector vaccine immunogenicity.

    Nicholas M. Provine;Ali Amini;Lucy C. Garner;Alexandra J. Spencer

  • Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

    E Spada;A Mele;A Berton;L Ruggeri

Frequent Co-Authors

Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Riccardo Cortese
Riccardo Cortese Schering-Plough
Paul Klenerman
Paul Klenerman University of Oxford
Eleanor Barnes
Eleanor Barnes University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Maria Rosaria Capobianchi
Maria Rosaria Capobianchi National Institutes of Health
Andrew J. Leigh Brown
Andrew J. Leigh Brown University of Edinburgh
Alfonso Mele
Alfonso Mele Istituto Superiore di Sanità
Evan W. Newell
Evan W. Newell Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare roles, many of which can be enhanced by pursuing advanced nursing degrees. For those interested in mental health, exploring the cheapest online pmhnp programs offers an affordable pathway to becoming a Psychiatric-Mental Health Nurse Practitioner, a role that frequently intersects with immunological research in neuroimmune disorders.

Nurses aiming for leadership and specialized clinical roles often consider a Doctor of Nursing Practice (DNP). Understanding how much do dnps make nationally can help prospective students assess the return on investment and plan their educational paths accordingly.

If you are a Family Nurse Practitioner (FNP) looking to specialize further, transitioning through acnp programs is a strategic move. Acute Care Nurse Practitioners work closely with immunocompromised patients, showcasing the relevance of immunology in acute clinical settings.

For registered nurses eager to advance quickly, the accelerated rn to np programs provide a streamlined route to becoming a Nurse Practitioner. These programs cater to professionals wanting to deepen their understanding of immunology-related conditions while advancing their careers.

Best Scientists Citing Antonella Folgori

Trending Scientists